Dr Dennis Gillings, consultant to the pharmaceutical industry and founder of Quintiles, has been appointed by the UK Prime Minister as the World Dementia Envoy. The creation of this role was agreed at the G8 dementia summit in December 2013.
The envoy plans to create a World Dementia Council to stimulate innovation, development and commercialisation of life enhancing drugs, treatments and care for people with dementia, and to protect those at risk of dementia, within a generation. The council will be independent of government and will have expertise in pharmaceuticals, research, investment and civic society. The first members of the council will be announced shortly.
Dr Gillings has more than 30 years’ experience in biopharmaceutical development, and has provided consultation to numerous companies and health organisations. Quintiles is the largest provider of biopharmaceutical development and commercial outsourcing services. Dr Gillings, who was born and educated in the UK, was awarded a CBE in 2004 for services to the pharmaceutical industry.
Find out more about the World Dementia Council.